Business

PDMR Dealings / Market Share Sale

PDMR Dealings / Market Share Sale.

articleOxford Biomedica PlcAugust 10, 20185/company/oxford-biomedica-plc/news/pdmr-dealings-market-share-sale-1
PDMR Dealings / Market Share Sale

About this update from Oxford Biomedica Plc

[{"type":"text","content":"\n \nRNS Number : 4917X Oxford Biomedica PLC 10 August 2018  \n\n \n \n \n \n \n \nPDMR Dealings / Market Share Sale \n \nOxford, UK - 10 August 2018: Oxford BioMedica plc (\"Oxford BioMedica\" or \"the Company\") (LSE: OXB), a leading gene and cell therapy group, was informed that on 07 August 2018 Jason Slingsby, Chief Business Officer, exercised 5,334 options at 487.4p, exercised 7,139 options at 490.0p and 6,155 options at 487.4p and sold all of the resulting shares at 890.1p. \n \nFollowing this transaction he holds 68,929 options and no shares in the company.\n \nThe issued share capital of the Company is 65,752,788 ordinary shares of 50 pence each.\nThe Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.\n \nNotification of Dealing Form\n \n\n\n\n\n1.\n\n\nDetails of the Person Discharging Managerial Responsibility (\"PDMR\")/person closely associated with them (\"PCA\")\n\n\n\n\na)\n\n\nName\n\n\nJason Slingsby\n\n\n\n\n2.\n\n\nReason for the notification\n\n\n\n\na)\n\n\nPosition/status\n\n\nChief Business Officer\n \n\n\n\n\nb)\n\n\nInitial notification/\namendment\n\n\nInitial Notification\n\n\n\n\n3.\n\n\nDetails of the Issuer\n\n\n\n\na)\n\n\nName\n\n\nOxford BioMedica plc\n\n\n\n\nb)\n\n\nLEI code\n\n\n213800S1GVQNXQ15K851\n\n\n\n\n4.\n\n\nDetails of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted\n\n\n\n\na)\n\n\nDescription of the financial instrument\n \nIdentification code\n\n\nOrdinary Shares of 50 pence each\n \nISIN: GB00BDFBVT43\n\n\n\n\nb)\n\n\nNature of the transaction\n\n\nExercise of options\n\n\n\n\nc)\n\n\nCurrency\n\n\nGBP - British pound\n\n\n\n\nd)\n\n\nPrice(s) and volumes(s)\n\n\n \n\n\n\n\nPrice(s)\n\n\nVolume(s)\n\n\n\n\n£4.874\n\n\n5,334\n\n\n\n\n£4.900\n\n\n7,139\n\n\n\n\n£4.874\n\n\n6,155\n\n\n\n\n \n \n\n\n\n\ne)\n\n\nAggregated information\n-   Aggregate volume\n \n-   Price\n \n-   Aggregated total\n \n\n\n \n18,628\n \n \n£4.884\n \n£90,978.49\n\n\n\n\nf)\n\n\nDate of the transaction\n\n\n2018-08-07\n\n\n\n\ng)\n\n\nPl...

More updates from Oxford Biomedica Plc